The Board of Directors of listed company Navana Pharmaceuticals Limited has disclose the unaudited financial report for the third quarter (January 23-March 23).

It was released after reviewing and approving the report at the company's board meeting held on Thursday (April 13).

According to company sources, the company's earnings per share (EPS) in the third quarter (January 23-March 23) was Tk 1.09. Earnings per share (EPS) was Tk 0.85 in the same period last fiscal.

On the other hand, the earnings per share (EPS) of the company in 9 months (July, 22-March, 23) was 2 Tk 0.57. Earnings per share (EPS) was Tk 2.39 in the corresponding period last fiscal.

At the end of March 31, 2023, the company's assets per share (NAV) stood at Tk 40.90.

nj